辉瑞(Pfizer)和德国BioNTech在周三表示,最终分析发现他们的候选疫苗在预防Covid,抵御严重疾病中95%有效。 本周早些时候,美国Moderna表示初步的第三期试验数据显示疫苗具有94.5%的有效性。 Oxford-AstraZeneca Covid vaccine shows robust immune response among older adultswww.cnbc.com/2020/11/19/oxford-covid-va...
AstraZeneca has begun a global withdrawal of its COVID-19 vaccine. Its vaccine, called Vaxzevria, will no longer be distributed in the European Union. 中文版本今日新闻图件。 A AstraZeneca has begun a global withdrawal of its COVID-19 vaccine. Its vaccine, called Vaxzevria, will no longer...
参考资料: [1] Oxford University/AstraZeneca vaccine authorised by UK medicines regulator. Retrieved December 30, 2020, from网页链接 [2] AZD1222 Oxford Phase III trials interim analysis results published in The Lancet. Retrieved December 30, 2020, from网页链接 [3] AstraZeneca’s COVID-19 vaccine...
CANBERRA, June 17 (Xinhua) -- Australian Health Minister Greg Hunt said on Thursday that the Australian Technical Advisory Group on Immunisation (ATAGI) has advised that the AstraZeneca COVID-19 vaccine be administered to people aged 60 and over, rather than those aged 50 and over as was pr...
AstraZeneca said its vaccine, developed in collaboration with the University of Oxford, was assessed over two different dosing regimens. One showed an effectiveness of 90% when trial participants received a half dose, followed by a full dose at least one month apart. The other dosing regimen sho...
“这项建议是根据挪威药品管理局的一份报告作出的,该报告报道了在接种Covid-19疫苗阿斯利康疫苗后成年人中出现严重血液凝结事件的新报告。 “It has not been concluded that there is any link between the Covid-19 vaccine AstraZeneca and these cases. However, acting on the precautionary principle, and pe...
BANGKOK, March 12 (Xinhua) -- Thailand announced Friday to temporarily halt the roll-out of AstraZeneca COVID-19 vaccination after some European nations suspended the use of the vaccine due to concerns of blood clotting. "It is not certain whether the blood clot symptom is directly related to...
A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of ...
Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19 vaccine have concluded that these are a "possible" and "extremely rare" side effect. Neither agency established a causal relation. However, although both regulators concluded ...
BRUSSELS, Jan. 12 (Xinhua) -- The European Medicines Agency (EMA) said on Tuesday it had received the application for conditional marketing authorization for a COVID-19 vaccine developed by AstraZeneca and Oxford University, and it could make a recommendation by the end of January through an ...